News
Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...
In summary, flashbacks that reproduce components of the psychedelic drug experiences after the administration of therapeutic doses are a relatively common phenomenon in clinical trials. Overall, the ...
Tel Aviv University announced on Wednesday that the surgery will take place in Israel, marking a historic milestone in ...
Type 1 diabetes rates are rising, but breakthrough drugs and devices are changing what it means to live with the disease.
The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.
Human stem cells developed into dopaminergic neurons have been transplanted into mice, resulting in reduced anxiety and ...
12h
Pharmaceutical Technology on MSNFDA awards breakthrough therapy status to BMS and SystImmune’s NSCLC drug
B ristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...
FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond ...
1d
Zacks Investment Research on MSNMRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer
Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd antibody-drug conjugate (ADC), ifinatamab deruxtecan (I-DXd), for treating adult ...
The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...
Earlier this month, we learned 22-year-old Daniel Cressy would become the first person in Louisiana to receive a gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results